A Market Research Engine report predicts the worldwide spine biologics market will reach over $2.5 billion by 2022 at a 4.4% growth rate because of technological advancements, demand for minimally invasive surgery, advantages of biologics and new devices, and treatment techniques. Among the key market players are DePuy Spine, Stryker, Medtronic, Smith & Nephew, Zimmer Spine and NuVasive.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.